Shanghai Junshi Biosciences Plans to Invest Up to RMB 2 Billion in Idle Proceeds in Principal-Guaranteed Products

By Public Technologies
  • Shanghai Junshi Biosciences plans to invest up to RMB 2 billion of temporarily idle proceeds in principal-guaranteed investment products.
  • The authorization runs from November 27, 2026, to November 26, 2027; funds may be reinvested within the limit.
  • Individual investments will mature within 12 months, without affecting funding for planned investment projects.
  • Investment income will prioritize project funding shortfalls and daily working capital needs.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Junshi Biosciences Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261029-12388587), on October 29, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk